Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain
Coronavirus
DOI:
10.1128/spectrum.01352-21
Publication Date:
2021-10-13T17:00:24Z
AUTHORS (27)
ABSTRACT
COVID-19 is a respiratory disease caused by severe acute syndrome coronavirus 2 (SARS-CoV-2). The pandemic has posed serious threat to global health and the economy, so it necessary find safe effective antibody drugs treatments.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (15)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....